PEG Derivatives
Chemical Additives 2025-03-18
PEG Derivatives: Versatile Functional Polymers
1. Definition & Structure
- PEG Derivatives are polyethylene glycol (PEG)-based compounds chemically modified with functional groups (e.g., –OH, –NH₂, –COOH, –SH).
- General formula: H-(O-CH₂-CH₂)ₙ-X (where X = reactive terminal group).
- Key Features:
- Water-soluble (hydrophilic).
- Biocompatible & low toxicity (FDA-approved for pharmaceuticals).
- Tunable properties via PEG chain length (n = degree of polymerization).
2. Common Types & Functional Groups
| Type | Functional Group | Example Applications |
|---|---|---|
| Methoxy PEG (mPEG) | –OCH₃ | Drug conjugation, surface coating. |
| PEG Amine (PEG-NH₂) | –NH₂ | Bioconjugation, gene delivery. |
| PEG Carboxyl (PEG-COOH) | –COOH | Protein modification, hydrogel synthesis. |
| PEG Thiol (PEG-SH) | –SH | Gold nanoparticle stabilization, bioassays. |
| PEG Maleimide (PEG-MAL) | Maleimide | Site-specific antibody-drug conjugates (ADCs). |
3. Key Properties & Advantages
| Property | Benefit |
|---|---|
| Water Solubility | Enhances solubility of hydrophobic drugs (e.g., PEGylated liposomes). |
| Stealth Effect | Reduces immune recognition (prolongs circulation time of drugs). |
| Biocompatibility | Safe for medical use (e.g., PEG in vaccines & injectables). |
| Surface Modification | Prevents protein adsorption (anti-fouling coatings). |
4. Applications
- Pharmaceuticals & Drug Delivery
- PEGylation: Attaching PEG to proteins/peptides (e.g., PEG-interferon for hepatitis C).
- Nanocarriers: PEGylated nanoparticles (e.g., mRNA vaccines, doxorubicin liposomes).
- Biotechnology
- Protein Stabilization: Prevents aggregation (e.g., PEGylated enzymes).
- Diagnostics: PEG-coated quantum dots for imaging.
- Cosmetics & Personal Care
- Moisturizers: PEG-8, PEG-40 in creams.
- Solubilizers: For fragrances & essential oils.
- Industrial Uses
- Lubricants: PEG-based synthetic oils.
- Adhesives: Water-soluble PEG diacrylates.
5. Safety & Regulatory Status
- FDA/EMA-Approved: For drug delivery (e.g., PEG 3350 in laxatives).
- Controversies: Rare anti-PEG immunity (allergic reactions in some individuals).
- Alternatives: Developing non-PEG polymers (e.g., polysarcosines).
